Search

Renowned cancer biologist Joan Massagué, PhD, has been named Director of the Sloan Kettering Institute, one of the most dynamic and robust cancer research programs in the United States, and the research arm of Memorial Sloan Kettering Cancer Center.

… Monday, November 25, 2013 Renowned cancer biologist Joan Massagué, PhD , has been named Director of the Sloan Kettering Institute , one of the most dynamic and robust cancer research programs in the United States, and the research arm of Memorial Sloan Kettering Cancer Center. Dr. Massagué, Chair of

There is concern that mastectomy is over-utilized in the United States, which raises questions about the role of surgeons and patient preference in treatment selection for breast cancer. New data from an observational study published in the October 14 issue of the Journal of the American Medical Association, a theme issue on surgical care, found that breast-conserving surgery was presented and provided in the majority of patients evaluated.

… Tuesday, October 13, 2009 Breast-Conserving Surgery Offered to the Majority of Patients There is concern that mastectomy is over-utilized in the United States, which raises questions about the role of surgeons and patient preference in treatment selection for breast cancer . New data from an observational

A new study by investigators at Memorial Sloan Kettering Cancer Center (MSK) found no evidence of an increased risk of biochemical recurrence with any PDE5 inhibitor use or duration in the first year following radical prostatectomy.

… Tuesday, March 5, 2024 There have been conflicting studies on whether phosphodiesterase type 5 (PDE5) inhibitors, such as sildenafil or tadalafil, are associated with an increased risk of biochemical recurrence after radical prostatectomy for prostate cancer. A new study by investigators at Memorial

An MSK geriatrician discusses the importance of helping older people with cancer manage their treatment and symptoms.

… Tuesday, July 9, 2019 Summary Older people with cancer are especially vulnerable to health setbacks during and after treatment. MSK geriatrician Armin Shahrokni explains how monitoring symptoms closely can reduce the risk of serious problems that require a hospital stay. Memorial Sloan Kettering geriatrician

The New York Yankees and Memorial Sloan Kettering Cancer Center have announced a new and unprecedented initiative to raise funds to help support research and treatment for children with cancer.

… Monday, April 10, 2006 Proceeds Aimed at Making a World of Difference to Children with Cancer The New York Yankees and Memorial Sloan Kettering Cancer Center have announced a new and unprecedented initiative to raise funds to help support research and treatment for children with cancer. Memorial Sloan

GSK’s Fourth Biennial Retreat on May 6 and 7 at the Mohonk Mountain House in New Paltz, New York, will feature former Sloan Kettering Institute Director Dr. Thomas J. Kelly.

… Monday, May 2, 2016 The Gerstner Sloan Kettering Graduate School of Biomedical Sciences’ fourth Biennial Retreat will take place from May 6 through May 7, 2016, at the Mohonk Mountain House in New Paltz, New York. The retreat will celebrate the first decade of matriculants in GSK’s graduate program.

Memorial Sloan Kettering Cancer Center announced it has selected Epic to provide a new platform for integrated care that will ensure patients and physicians can more easily access electronic health records.

… Monday, November 21, 2022 Memorial Sloan Kettering Cancer Center (MSK) today announced it has selected Epic to provide a new platform for integrated care that will ensure patients and physicians can more easily access electronic health records (EHR). Implementing Epic is an important milestone that will

Memorial Sloan Kettering Cancer Center physician-scientists report that women with small, node-negative, HER2-positive breast cancer may obtain a significant benefit from adjuvant chemotherapy with trastuzumab (Herceptin®), a drug previously shown to improve outcomes in advanced cancer and prevent the return of cancer in women diagnosed with higher-risk, early-stage, HER2-positive breast cancer. This study appears online in the journal Cancer, and will be published in a future print edition.

… Friday, June 24, 2011 Memorial Sloan Kettering Cancer Center physician-scientists report that women with small, node-negative, HER2 -positive breast cancer may obtain a significant benefit from adjuvant chemotherapy with trastuzumab (Herceptin ® ), a drug previously shown to improve outcomes in advanced

Learn how MSK’s Antibiotic Management Program is leading the way in ensuring that antibiotics and other antimicrobial drugs are used responsibly.

… Wednesday, May 22, 2019 Summary In this Q & A, infectious disease expert Susan Seo discusses MSK’s Antibiotic Management Program. It ensures that antibiotics and other antimicrobial drugs are used responsibly. The rapid emergence of drug-resistant microorganisms is “a global crisis that threatens a century

MSK is proud to announce that four Sloan Kettering Institute (SKI) researchers have been named 2024 Marie-Josée Kravis Women in Science Endeavor (Kravis WISE) fellowship grant recipients.

… Thursday, February 29, 2024 Each year, the Marie-Josée Kravis Women in Science Endeavor (WISE) initiative awards several fellowships to female graduate students and postdoctoral fellows to support their research at Memorial Sloan Kettering Cancer Center (MSK). The awards are announced in March, to coincide